PE
ASTH icon

Point72 Europe’s Astrana Health ASTH Stock Holding History

Point72 Europe’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$6.42K Buy
+226
New +$6.12K ﹤0.01% 579

Other funds holding ASTH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Point72 Europe's ASTH Position: Q3 2025 in Review

Point72 Europe opened a new position in Astrana Health (ASTH) in Q3 2025: 226 shares worth $6.42K. The stake represents ﹤0.01% of the portfolio and ranks #579 among its holdings.

188 funds tracked by Wall St. Rank hold ASTH as of Q3 2025.

  • Point72 Europe held 226 shares of Astrana Health worth $6.42K as of Q3 2025.
  • Astrana Health was a new Point72 Europe position in Q3 2025.
  • Astrana Health made up ﹤0.01% of Point72 Europe's portfolio in Q3 2025, its #579 holding.
  • 188 funds tracked by Wall St. Rank held Astrana Health as of Q3 2025.

Based on Point72 Europe's 13F filing for Q3 2025, filed 14 Nov 2025.